1Kotlyar E, Keogh AM, Macdonald PS, et al. Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma[J]. J Heart Lung Transplant,2002,21(12):1290-1295.
2Haas SJ, Vos T, Gilbert RE, et al. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials[J]. Am Heart J,2003,146(5):848-8
3Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% trea
4Poole-Wilson PA, Swedberg K, Cleland JG, et al. Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COME
5Cleland JG, Pennell DJ, Ray SG, et al. Carvedilol hibernating reversible ischaemia trial: marker of success investigators. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS tria
6CIBIS-II Investigators and Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial[J]. Lancet,1999,353(9146):9-13.
7Ormiston TM, Salpeter SR. Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice[J]. Heart Fail Monit,2003,4(2):45-54.
8Khand AU, Rankin AC, Martin W, et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure[J]? J Am Coll Cardiol,2003,42(11):1944-1951.
9Camsari A, Pekdemir H, Akkus MN, et al. Long-term effects of beta blocker therapy on P-wave duration and dispersion in congestive heart failure patients: a new effect[J]? J Electrocardiol,2003,36(2):111-116.
10Nichols GA, Hillier TA, Erbey JR, et al. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors[J]. Diabetes Care,2001,24(9):1614-1619.
5Packer M. Therapeutic options in the management of chronic heart failure[J]. Circulation, 1989,79 : 198.
6CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure:the Cardiac Insufficiency Bisoprolol Study (CIBIS) [J]. Circulation, 1996,94 : 2800.
7E M, Kaye D, Lambert G,et al. Adrenergic nervous system in heart failure[J]. Am J Cardio, 1997,80: 7.
8Bristow M R. Mechanism of action of beta-blocking agents in heart failure[J]. Am J Cardio,1997,80:26.
10Senior R,Sumit MB,Christopher K,et al.Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction[J].Am Heart J,1999,137(3):646-652.
